AbbVie to Host Fourth-Quarter and Full-Year 2020 Earnings Conference Call
Tue, January 12, 2021, 8:00 AM EST

AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2020 financial results on Wednesday, February 3, 2021, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:http://www.prnewswire.com/news-releases/abbvie-to-host-fourth-quarter-and-full-year-2020-earnings-conference-call-301205553.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Village Farms International, Inc. (VFF) to Host Earnings Call

Village Farms International, Inc. to Host Earnings Call Village Farms International, Inc.…

MariMed, Inc. (MRMD) Appoints Jon Levine as Interim Chief Executive Officer

MariMed Appoints Jon Levine as Interim Chief Executive Officer MariMed, Inc. (“MariMed”…

Leafbuyer Technologies, Inc. (LBUY) Books Strong 36% Cash Sales Growth in Latest Quarter

DENVER–(BUSINESS WIRE)– Leafbuyer Technologies, Inc. (LBUY) (“Leafbuyer” or “the Company”) a leading…

$EAPH Brings in Auditor Kapadia Chartered Accountants PC to Audit Finances for Years 2013 and 2014

Easton Pharmaceuticals Engages Accredited Independent Auditor to Commence an Audit of Company’s…